Patient- and population-based informatic tools are needed to improve early identification of chronic kidney disease, given stagnant recognized incidence rates of 10.3 to 9.5 per 1000 from 2012 to 2021.
Do patient- and population-based informatic tools improve the early identification of CKD by general practitioners?
Patient- and population-based informatics tools are needed to enhance the early identification of CKD by general practitioners and facilitate the timely administration of effective pharmacotherapies.
Chronic kidney disease (CKD) is a global public health issue that can lead to several complications such as, kidney failure, cerebro/cardiovascular disease, and death. There is a well-documented "awareness gap" among general practitioners (GPs) to recognize CKD. As shown by estimates stemming from the Health Search Database (HSD) of the Italian College of General Practitioners and Primary Care (SIMG), no substantial changes were observed in terms of the incident rate of CKD over the last 10 years. Namely, 10.3-9.5 per 1000 new cases of CKD were estimated in 2012 and 2021, respectively. Thus, strategies to reduce under-recognized cases are needed. Early identification of CKD might improve patient's quality of life and clinical outcomes. In this context, patient- and population-based informatic tools may support both opportunistic and systematic screening of patients at greater risk of CKD. As such, the new effective pharmacotherapies for CKD would be proficiently administered. To this aim, these two complimentary tools have been developed and will be further implemented by GPs. The effectiveness of these instruments in identifying the condition at an early stage and reducing the burden of CKD on the national health system needs to be verified according to the new regulations on medical device (MDR: (EU) 2017/745).
Lapi et al. (Mon,) conducted a editorial in Chronic kidney disease (CKD). Patient- and population-based informatic tools was evaluated. Patient- and population-based informatic tools are needed to improve early identification of chronic kidney disease, given stagnant recognized incidence rates of 10.3 to 9.5 per 1000 from 2012 to 2021.